chr16-58020195-C-G
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_024598.4(USB1):āc.748C>Gā(p.Gln250Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0751 in 1,614,084 control chromosomes in the GnomAD database, including 5,166 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.
Frequency
Consequence
NM_024598.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
USB1 | NM_024598.4 | c.748C>G | p.Gln250Glu | missense_variant | 7/7 | ENST00000219281.8 | |
USB1 | NM_001195302.2 | c.694C>G | p.Gln232Glu | missense_variant | 6/6 | ||
USB1 | NM_001330568.2 | c.595C>G | p.Gln199Glu | missense_variant | 7/7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
USB1 | ENST00000219281.8 | c.748C>G | p.Gln250Glu | missense_variant | 7/7 | 1 | NM_024598.4 |
Frequencies
GnomAD3 genomes AF: 0.0585 AC: 8904AN: 152124Hom.: 380 Cov.: 31
GnomAD3 exomes AF: 0.0690 AC: 17355AN: 251428Hom.: 717 AF XY: 0.0719 AC XY: 9774AN XY: 135892
GnomAD4 exome AF: 0.0769 AC: 112366AN: 1461842Hom.: 4785 Cov.: 32 AF XY: 0.0775 AC XY: 56388AN XY: 727216
GnomAD4 genome AF: 0.0584 AC: 8894AN: 152242Hom.: 381 Cov.: 31 AF XY: 0.0574 AC XY: 4273AN XY: 74430
ClinVar
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 27, 2018 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 29, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at